We are live on ! Find out more
BM

Brandywine Managers Portfolio holdings

AUM $170M
1-Year Est. Return 10.01%
This Fund
S&P 500
This Quarter Est. Return
+0.85%
1 Year Est. Return
+10.01%
3 Year Est. Return
+53.1%
5 Year Est. Return
+7.42%
10 Year Est. Return
+248.69%
AUM
$28.6M
AUM Growth
-$1.78M
Cap. Flow
-$13.2K
Cap. Flow %
-0.05%
Top 10 Hldgs %
60.06%
Holding
41
New
2
Increased
3
Reduced
2
Closed
4

Sector Composition

1 Technology 55.54%
2 Healthcare 34.04%
3 Consumer Staples 4.76%
4 Financials 3.34%
5 Consumer Discretionary 1.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDGR icon
26
Schrodinger
SDGR
$1.17B
$390K 1.36%
20,886
SNOW icon
27
Snowflake
SNOW
$93.6B
$366K 1.28%
2,549
NOW icon
28
ServiceNow
NOW
$107B
$347K 1.21%
4,465
IOT icon
29
Samsara
IOT
$21.8B
$318K 1.11%
25,578
BEAM icon
30
Beam Therapeutics
BEAM
$2.92B
$316K 1.1%
8,067
-5,000
-38% -$224K
SMAR
31
DELISTED
Smartsheet Inc.
SMAR
$303K 1.06%
7,700
DNLI icon
32
Denali Therapeutics
DNLI
$3.61B
$267K 0.93%
9,601
QTRX icon
33
Quanterix
QTRX
$187M
$264K 0.92%
19,065
DOCU
34
DocuSign
DOCU
$10.2B
$233K 0.82%
4,211
RBLX icon
35
Roblox
RBLX
$38.7B
$206K 0.72%
7,241
FULC icon
36
Fulcrum Therapeutics
FULC
$233M
$190K 0.66%
26,127
CELL
37
DELISTED
PhenomeX Inc. Common Stock
CELL
$79.8K 0.28%
29,772
-25,000
-46% -$65.9K
IONS icon
38
Ionis Pharmaceuticals
IONS
$9.03B
-8,460
Closed -$374K
S icon
39
SentinelOne
S
$6.73B
-7,900
Closed -$202K
SEER icon
40
Seer Inc
SEER
$119M
-15,366
Closed -$119K
VRNS icon
41
Varonis Systems
VRNS
$5.4B
-13,580
Closed -$360K

Similar funds

Brandywine Managers's Q4 2022 Portfolio in Review

As of Q4 2022, Brandywine Managers held 41 positions worth $28.6M, down 5.9% from $30.4M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Brandywine Managers's Q4 2022 filing shows 2 new, 3 increased, 2 reduced and 4 closed positions. Its largest new stake was Prime Medicine: 32,977 shares worth $613K. The largest sale was Ionis Pharmaceuticals, an estimated $374K.

By sector, the portfolio is most concentrated in Technology at 56% of assets, down from 61% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Brandywine Managers's largest Q4 2022 buy was Prime Medicine: 32,977 shares worth $613K.
  • Brandywine Managers added most to CrowdStrike in Q4 2022, an estimated $122K increase.
  • Brandywine Managers's biggest Q4 2022 reduction was Beam Therapeutics, cutting an estimated $224K.
  • Brandywine Managers fully exited Ionis Pharmaceuticals in Q4 2022, selling an estimated $374K.
  • Brandywine Managers's ten largest holdings make up 60% of its $28.6M portfolio in Q4 2022.
  • Brandywine Managers opened 2 new positions and closed 4 in Q4 2022.
  • Brandywine Managers's portfolio value fell 5.9% quarter-over-quarter to $28.6M.

Based on Brandywine Managers's 13F filing for Q4 2022, filed 14 Feb 2023.